As of 2024-12-13, the Relative Valuation of ZIOPHARM Oncology Inc (ZIOP) is (7.53) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.87 USD, the upside of ZIOPHARM Oncology Inc based on Relative Valuation is -970.3%.
The range of the Relative Valuation is (4.68) - (7.94) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 24.4x | 17.5x |
| Forward P/E multiples | 11.3x - 19.1x | 18.8x |
| Fair Price | (4.68) - (7.94) | (7.53) |
| Upside | -640.9% - -1016.8% | -970.3% |
| Date | P/E |